SCHEMBL4133812

SCHEMBL4133812

CCCc1nn(C)c2c(=O)[nH]c(N(CCCC(F)(F)F)Cc3ccc(Cl)c(Cl)c3)nc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 14/20 0.42
MTOR P42345 1/20 0.40
PDE3B Q13370 2/20 0.39
PDE3A Q14432 2/20 0.39
PDE1A P54750 2/20 0.39
PDE1B Q01064 2/20 0.39
PDE1C Q14123 2/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
TERT O14746 2/20 0.38
PDE6C P51160 2/20 0.37
PDE2A O00408 1/20 0.37
ABCC4 O15439 1/20 0.37
ABCC5 O15440 1/20 0.37
PDE6D O43924 1/20 0.37
PDE8A O60658 1/20 0.37
PDE9A O76083 1/20 0.37
ABCB11 O95342 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4897792 0.92 PDE5A (0.46) PDE5AMTORPDE3BPDE3APDE1A
SCHEMBL4902063 0.86 PDE5A (0.44) PDE5AMTORPDE3BPDE3APDE1A
SCHEMBL4902249 0.82 PDE5A (0.49) PDE5AMTORPDE3BPDE3APDE1A
SCHEMBL4132769 0.80 PDE5A (0.42) PDE5AMTORPDE3BPDE3APDE1A
SCHEMBL4125332 0.75 PDE5A (0.46) PDE5AMTORPDE3BPDE3APDE1A
SCHEMBL4899916 0.74 PDE5A (0.50) PDE5AMTORPDE3BPDE3APDE1A
SCHEMBL4902005 0.73 PDE5A (0.56) PDE5AMTORPDE3BPDE3APDE1A
SCHEMBL4903970 0.72 PDE5A (0.50) PDE5AMTORPDE3BPDE3A
SCHEMBL4898303 0.72 PDE5A (0.48) PDE5AMTORPDE3BPDE3APDE1A
SCHEMBL4902017 0.72 PDE5A (0.52) PDE5AMTORPDE3BPDE3APDE1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009071706-A1 PYRAZOLEPYRIMIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES GALAPAGOS NV (BE) 2009-06-11 WO disclosed